Treatment of transient hypothyroxinemia of prematurity: A survey of neonatal practice

Abstract

We mailed a survey on treatment practices for transient hypothyroxinemia of prematurity (THOP) to 100 randomly selected neonatologist. In the year before the survey, 13 of 62 respondents (21.0%) had treated an averages of 4.5 THOP patients with thyroid hormone hormone, and 3 had treated 10 or more patients. Randomized trials assessing the value of thyroid supplementation in THOP are urgently needed.